
Targeting the Heart of the Matter – Mineralys Therapeutics In Pursuit of Transformative Treatments for Hypertension and Adjacent Conditions
RADNOR, PA — Mineralys Therapeutics, Inc. (Nasdaq: MLYS) has unfurled its financial banners for the fourth quarter and full year closing December 31, 2023. Alongside these fiscal results, the company …
Targeting the Heart of the Matter – Mineralys Therapeutics In Pursuit of Transformative Treatments for Hypertension and Adjacent Conditions Read More